Rocky Mountain Diabetes and Osteoporosis Center — Idaho Falls, Idaho

Rocky Mountain Diabetes and Osteoporosis Center is a clinical research site located in Idaho Falls, Idaho, United States 83404.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

Rocky Mountain Diabetes and Osteoporosis Center has participated in 41 clinical trials with 2 currently active.

Therapeutic areas: Diabetes, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1.

Sponsors: DexCom, Inc., Eli Lilly and Company, Halozyme Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Idaho Falls

Browse all research sites in Idaho · View every site in Idaho Falls

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Diabetes and Osteoporosis Center?

Rocky Mountain Diabetes and Osteoporosis Center has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Diabetes and Osteoporosis Center conducted?

Rocky Mountain Diabetes and Osteoporosis Center has 41 clinical trials on record, with 2 currently active. Their work covers Diabetes, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1.

Is Rocky Mountain Diabetes and Osteoporosis Center accredited by Crixeo Clinical Trials?

Rocky Mountain Diabetes and Osteoporosis Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Diabetes and Osteoporosis Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.